AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Aromasin (exemestane tablets) is approved as an adjuvant treatment for post-menopausal women with estrogen receptor-positive breast cancer who have received 2-3 years of tamoxifen and are switched to Aromasin ...